E.大腸菌検査市場：検査別（臨床、環境）、エンドユーザー別（ボトル入り飲料水サプライヤー、診断ラボ、政府機関）-世界予測2023-2030年

E.大腸菌検査の世界市場は、2023年にCAGR 10.18%で9億9,617万米ドルが予測され、2030年には19億6,626万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のE.大腸菌検査市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.E.大腸菌検査の世界市場規模および予測は？

2.予測期間中、世界のE.大腸菌検査市場を形成するCOVID-19の阻害要因と影響は？

3.E.大腸菌検査の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.E.大腸菌検査の世界市場における競争戦略は？

5.E.大腸菌検査の世界市場における技術動向と規制の枠組みは？

6.E.大腸菌検査の世界市場における主要ベンダーの市場シェアは？

7.E.大腸菌検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 下痢の発生率の増加
    • 食品リコール件数の増加
    • インスタント食品の大量消費
  • 抑制要因
    • 大腸菌検査における標準化の欠如
  • 機会
    • 食品安全測定における革新的な技術のイントロダクション
    • 病原体検査を改善するためのPCR技術の継続的な開発
  • 課題
    • 食品と水の検査に伴う高額なコスト
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 E.大腸菌検査市場テスト別

• 臨床
  • 酵素免疫測定法
  • ポリメラーゼ連鎖反応
• 環境
  • 酵素基質法
  • 膜ろ過
  • 多重管発酵

第7章 E.大腸菌検査市場：エンドユーザー別

• ボトル入り飲料水のサプライヤー
• 診断研究所
• 政府機関
• 家庭用水と飲料水のサプライヤー
• 病院
• 廃水処理業者

第8章 南北アメリカのE.大腸菌検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のE.大腸菌検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのE.大腸菌検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. E. COLI TESTING MARKET RESEARCH PROCESS
• FIGURE 2. E. COLI TESTING MARKET SIZE, 2022 VS 2030
• FIGURE 3. E. COLI TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. E. COLI TESTING MARKET SIZE, BY TESTING, 2022 VS 2030 (%)
• FIGURE 5. E. COLI TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 6. E. COLI TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. E. COLI TESTING MARKET DYNAMICS
• FIGURE 8. E. COLI TESTING MARKET SIZE, BY TESTING, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. E. COLI TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. E. COLI TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. E. COLI TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 5. E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 6. E. COLI TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. E. COLI TESTING MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 10. E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. E. COLI TESTING MARKET SIZE, BY ENZYME SUBSTRATE METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. E. COLI TESTING MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. E. COLI TESTING MARKET SIZE, BY MULTIPLE TUBE FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. E. COLI TESTING MARKET SIZE, BY BOTTLED WATER SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. E. COLI TESTING MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. E. COLI TESTING MARKET SIZE, BY HOME & DRINKING WATER SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. E. COLI TESTING MARKET SIZE, BY WASTE WATER TREATMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 35. CANADA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 36. CANADA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 37. CANADA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CHINA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 57. CHINA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 58. CHINA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 59. CHINA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. INDIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 61. INDIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 62. INDIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 63. INDIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ITALY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 130. ITALY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 131. ITALY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 132. ITALY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. POLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 146. POLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 147. POLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 148. POLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. QATAR E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 150. QATAR E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 151. QATAR E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 152. QATAR E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 190. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 191. E. COLI TESTING MARKET LICENSE & PRICING

The Global E. Coli Testing Market is forecasted to grow significantly, with a projected USD 996.17 million in 2023 at a CAGR of 10.18% and expected to reach a staggering USD 1,966.26 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global E. Coli Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global E. Coli Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Testing, market is studied across Clinical and Environmental. The Clinical is further studied across Enzyme Immunoassays and Polymerase Chain Reaction. The Environmental is further studied across Enzyme Substrate Methods, Membrane Filtration, and Multiple Tube Fermentation. The Environmental is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Bottled Water Suppliers, Diagnostic Laboratories, Government Agencies, Home & Drinking Water Suppliers, Hospitals, and Waste Water Treatment Agencies. The Bottled Water Suppliers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global E. Coli Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global E. Coli Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global E. Coli Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global E. Coli Testing Market?

4. What is the competitive strategic window for opportunities in the Global E. Coli Testing Market?

5. What are the technology trends and regulatory frameworks in the Global E. Coli Testing Market?

6. What is the market share of the leading vendors in the Global E. Coli Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global E. Coli Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. E. Coli Testing Market, by Testing, 2022 vs 2030
• 4.3. E. Coli Testing Market, by End-User, 2022 vs 2030
• 4.4. E. Coli Testing Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of diarrhea
    • 5.1.1.2. Rise in numbers of food recalls
    • 5.1.1.3. Significant consumption of convenience foods
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standardizations in E.coli testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of innovative technologies in food safety measurements
    • 5.1.3.2. Ongoing developments of PCR technology for improved pathogen testing
  • 5.1.4. Challenges
    • 5.1.4.1. Associated high cost of testing food and water
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. E. Coli Testing Market, by Testing

• 6.1. Introduction
• 6.2. Clinical
  • 6.2.1. Enzyme Immunoassays
  • 6.2.2. Polymerase Chain Reaction
• 6.3. Environmental
  • 6.3.1. Enzyme Substrate Methods
  • 6.3.2. Membrane Filtration
  • 6.3.3. Multiple Tube Fermentation

7. E. Coli Testing Market, by End-User

• 7.1. Introduction
• 7.2. Bottled Water Suppliers
• 7.3. Diagnostic Laboratories
• 7.4. Government Agencies
• 7.5. Home & Drinking Water Suppliers
• 7.6. Hospitals
• 7.7. Waste Water Treatment Agencies

8. Americas E. Coli Testing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific E. Coli Testing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa E. Coli Testing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing